A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma

被引:25
|
作者
Khurana, Vinod K. [1 ,2 ]
Misri, Rachita R. [1 ,2 ]
Agarwal, Swati [1 ,2 ]
Thole, Akhilesh V. [1 ,2 ]
Kumar, Sachin [1 ,2 ]
Anand, Tanu [3 ]
机构
[1] Hindu Rao Hosp, Dept Dermatol, New Delhi, India
[2] Hindu Rao Hosp, Dept Venereol & Leprosy, New Delhi, India
[3] Hindu Rao Hosp, Dept Prevent & Social Med, New Delhi, India
关键词
Clinical trials preparation; melasma; therapeutic studies; tranexamic acid; TRANS-4-AMINOMETHYLCYCLOHEXANECARBOXYLIC ACID;
D O I
10.4103/ijdvl.IJDVL_801_16
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Melasma poses a great challenge as its treatment modalities are unsatisfactory. Treatment using tranexamic acid is a novel concept. Aim: This study aimed to compare the therapeutic efficacy and safety of oral tranexamic acid and tranexamic acid microinjections in patients with melasma. Methods: This is a prospective, randomized, open-label study with a sample size of 64, 32 in each treatment arm. Thirty-two patients were administered localized microinjections (4 mg/ml) of tranexamic acid monthly in 1 arm, while in the other arm, 32 were given oral tranexamic acid 250 mg twice a day. Patients were followed up for 3 consecutive months. Clinical photographs were taken at each visit, and a modified melasma area and severity index scoring was performed at the beginning and end of treatment. Results: Improvement in melasma area and severity index score in the oral group was 57.5% as compared to 43.5% in the intralesional group. All 32 patients in the oral group (100%) showed >50% improvement, out of which 8 showed >75% improvement. In the intralesional group, 17 (53%) patients had >50% improvement, of which 3 had >75% improvement. The remaining 15 patients in this group had <50% improvement. Thus, the oral group showed a more significant response as compared to the intralesional group. No major adverse effects were observed in both the groups. At 6-month follow-up, two patients (6.2%) in the oral group had recurrence as compared to three patients (9.4%) in the intralesional group. Limitations: A small sample size was one of the limitations in this study. The dose of tranexamic acid in microinjections and the frequency of injections could have been increased. Conclusion: Tranexamic acid provides rapid and sustained improvement in the treatment of melasma. It is easily available and affordable. Oral route is undoubtedly efficacious, but the results of microinjections, while encouraging, can probably be enhanced by either increasing the frequency of injections or increasing the concentration of the preparation.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 50 条
  • [1] Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study
    Sharma, R.
    Mahajan, V. K.
    Mehta, K. S.
    Chauhan, P. S.
    Rawat, R.
    Shiny, T. N.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2017, 42 (07) : 728 - 734
  • [2] Comparative study with administration of oral tranexamic acid for the treatment of melasma
    Karn, D.
    Kc, S.
    Timalsina, M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2013, 54 : 43 - 43
  • [3] A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma
    Rajsmita Bhattacharjee
    Vinod Hanumanthu
    Vishal Thakur
    Anuradha Bishnoi
    Keshavamurthy Vinay
    Ashok Kumar
    Davinder Parsad
    Muthu Sendhil Kumaran
    Archives of Dermatological Research, 2023, 315 : 1831 - 1836
  • [4] A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma
    Bhattacharjee, Rajsmita
    Hanumanthu, Vinod
    Thakur, Vishal
    Bishnoi, Anuradha
    Vinay, Keshavamurthy
    Kumar, Ashok
    Parsad, Davinder
    Kumaran, Muthu Sendhil
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (06) : 1831 - 1836
  • [5] A randomized open-label study to compare two different dosage regimens of oral tranexamic acid in treatment of moderate-to-severe facial melasma
    Keshavamurthy, Vinay
    Bhattacharjee, Rajsmita
    Hanumanthu, Vinod
    Thakur, Vishal
    Bishnoi, Anuradha
    Parsad, Davinder
    Kumaran, Muthu Sendhil
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [6] Oral tranexamic acid for the treatment of melasma
    Ali, F. R.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (03) : 347 - 349
  • [7] Feasibility of oral tranexamic acid for vitiligo patients with melasma
    Chiang, Pin-Hsuan
    Lin, Yu-, Jr.
    Chiu, Yen-Chuan
    Chung, Wen-Hung
    Ku, Cheng-Lung
    Ng, Chau Yee
    DERMATOLOGIC THERAPY, 2021, 34 (05)
  • [8] Oral tranexamic acid with laser treatments in melasma patients
    Park, H. S.
    Cho, H. H.
    Cho, S.
    Lee, J. H.
    PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (04) : 843 - 843
  • [9] The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial
    El Hadidi, Heba
    Mosaad, Rana
    Ragab, Nanis
    DERMATOLOGIC THERAPY, 2021, 34 (03)
  • [10] Comparative Study of Combination of Oral Tranexamic Acid With Modified Kligman's Formula Versus Oral Tranexamic Acid With Azelaic Acid 15% in the Treatment of Melasma
    Singh, Riddhima
    Maheshwari, Praveen
    Madke, Bhushan
    Singh, Adarshlata
    Jawade, Sugat
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)